{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:57:35Z","timestamp":1777309055652,"version":"3.51.4"},"reference-count":32,"publisher":"Academy of Managed Care Pharmacy","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.18553\/jmcp.2026.32.5.584","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:24:11Z","timestamp":1777307051000},"page":"584-595","source":"Crossref","is-referenced-by-count":0,"title":["Real-world adherence, persistence, and health care resource utilization among people with HIV receiving long-acting cabotegravir plus rilpivirine compared with oral antiretroviral therapy in the United States: The ABOVE Study"],"prefix":"10.18553","volume":"32","author":[{"given":"Cindy","family":"Garris","sequence":"first","affiliation":[{"name":"ViiV Healthcare, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maral","family":"DerSarkissian","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Chang","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Clear","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Liu","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Desai","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Teichner","sequence":"additional","affiliation":[{"name":"ViiV Healthcare, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar T.","family":"Overton","sequence":"additional","affiliation":[{"name":"ViiV Healthcare, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.22246"},{"key":"r2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00028-0"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190487"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-018-0214-y"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-03055-1"},{"key":"r6","unstructured":"Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Updated September 25, 2025. Accessed January 20, 2026. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/adult-adolescent-arv\/guidelines-adult-adolescent-arv.pdf"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.17507"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2019.25.1.088"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6849a1"},{"key":"r10","unstructured":"Cabenuva. Package insert. ViiV Healthcare; 2025."},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904398"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909512"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00136-4"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32666-0"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02929-8"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.7326\/M23-0788"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae500"},{"key":"r18","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01883-8"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00890-2"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.02.037"},{"key":"r21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00748.x"},{"key":"r22","unstructured":"ICON. Symphony health. Accessed December 4, 2025. https:\/\/www.iconplc.com\/solutions\/consulting\/commercial-positioning-consulting\/symphony-health"},{"key":"r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2024.100757"},{"key":"r24","unstructured":"Pharmacy Quality Alliance Measure overview. Updated May 2025. Accessed January 20, 2026. https:\/\/www.pqaalliance.org\/adherence-measures"},{"key":"r25","unstructured":"Cabenuva Dosing and Administration Guide\n                      . ViiV Healthcare; 2024."},{"key":"r26","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1995868"},{"key":"r27","unstructured":"Elixhauser A, Steiner C, Kruzikas D. HCUP comorbidity software. Healthcare cost and utilization project (HCUP). October 2015. Agency for Healthcare Research and Quality, Rockville, MD. Accessed December 5, 2025. https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/comorbidity\/comorbidity.jsp#download"},{"key":"r28","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13020269"},{"key":"r29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf120"},{"key":"r30","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02937-8"},{"key":"r31","unstructured":"Garris C, Kolobova I, Sarkar S, Sridhar G, Teichner P, Polk C. High real-world adherence with long-acting cabotegravir plus rilpivirine (CAB\u2009+\u2009RPV LA) among people with HIV (PWH) in the United States (US). Presented at: HIV-DART & Repsi-DART; December 1-5, 2024; Los Cabos, Mexico."},{"key":"r32","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S192735"}],"container-title":["Journal of Managed Care &amp; Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:24:56Z","timestamp":1777307096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2026.32.5.584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.18553\/jmcp.2026.32.5.584"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2026.32.5.584","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}